Maplelane Capital’s CME Group CME Stock Holding History

Maplelane Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-66,700	Closed	-$4.94M	–	120
2014 Q1	$4.94M	Buy	+66,700	New	+$5.03M	0.16%	85

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Maplelane Capital's CME Position: Q2 2014 in Review

Maplelane Capital sold out of CME Group (CME) in Q2 2014, closing a stake of 66,700 shares — an estimated $4.94M sold.

Maplelane Capital first reported a position in CME in Q1 2014 and held it in 1 quarter. The position peaked at $4.94M in Q1 2014. 538 funds tracked by Wall St. Rank hold CME as of Q2 2014.

Maplelane Capital reported no remaining CME Group position as of Q2 2014 after selling out during the quarter.
Maplelane Capital sold 66,700 CME Group shares in Q2 2014, an estimated $4.94M.
Maplelane Capital first reported a position in CME Group in Q1 2014 and held it in 1 quarter.
Maplelane Capital's CME Group position peaked at $4.94M in Q1 2014.
538 funds tracked by Wall St. Rank held CME Group as of Q2 2014.

Based on Maplelane Capital's 13F filing for Q2 2014, filed 14 Aug 2014.